A randomized phase II study of weekly paclitaxel with or without pelareorep in patients with metastatic breast cancer: final analysis of Canadian Cancer Trials Group IND.213.
Bernstein, V., Ellard, S. L., Dent, S. F., Tu, D., Mates, M., Dhesy-Thind, S. K., Panasci, L., Gelmon, K. A., Salim, M., Song, X., Clemons, M., Ksienski, D., Verma, S., Simmons, C., Lui, H., Chi, K.,Language:
english
Journal:
Breast Cancer Research and Treatment
DOI:
10.1007/s10549-017-4538-4
Date:
October, 2017
File:
PDF, 989 KB
english, 2017
File converter
More search results
More benefits 
